VolitionRx files patent for Ebola test using Nu.Q technology

Go back to VolitionRx files patent for Ebola test using Nu.Q technology
VolitionRX Limited (NYSE: VNRX) Delayed: 1.34 --0 (-0%)
Previous Close $1.34    52 Week High $5.86 
Open $1.34    52 Week Low $3.05 
Day High $1.34    P/E N/A 
Day Low $1.34    EPS $-0.45 
Volume 1,694